MedPath

Egg White for Phosphorus Control in Haemodialysis Patients

Not Applicable
Conditions
Hyperphosphatemia
Dialysis
Renal Insufficiency, Chronic
Interventions
Other: Egg White replacement
Registration Number
NCT03236701
Lead Sponsor
Federico II University
Brief Summary

To evaluate the effect on phosphatemia in hemodialysis patients of replacing the meat or fish included in two meals a week with an amount of egg white containing the same quantity of proteins.

Detailed Description

Hyperphosphatemia develops in the majority of patients with end-stage renal disease (ESRD). It is responsible for severe complications such as mineral bone disease, and has a role in worsening the cardiovascular mortality of dialyzed patients. Therefore, a close control of serum phosphorus remains a cornerstone in the clinical management of dialyzed patients to improve their long term prognosis. There are multiple sources of phosphorus in the diet that could be the target of such a dietary intervention but, because of important differences in bioavailability, they are not all equally relevant in influencing phosphatemia. Among them animal proteins that have a bioavailability of about 60% represent an important target for phosphate-lowering nutritional interventions. However, lowering the protein content of the diet in hemodialysis (HD) patients may be dangerous because it may increase the the risk of malnutrition hence worsening their prognosis. In the present study we intend to explore an alternative strategy to lower the intake of phosphate with animal proteins by replacing the meat or fish included in two meals a week with egg white that is reach of proteins but has virtually no phosphate.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • thrice weekly 4 h standard bicarbonate HD treatment with an at least 6-month vintage
  • stable dialysis dose and modality at least by 3 months
  • hyperphosphataemia (serum phosphate ≥5.0 mg/dl) at least by 3 months
  • stable dietary intake at least by 3 months
  • stable body weight at least by 3 months
  • stable biochemical markers at least by 3 months
Exclusion Criteria
  • diabetes
  • liver disease
  • malignancy
  • previous parathyroidectomy
  • psychiatric diseases
  • non-collaborative patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionEgg White replacementegg white instead of meat or fish in two meals twice a week for three months
Primary Outcome Measures
NameTimeMethod
Decrease in serum phosphate levelsPhosphate level will be measured monthly for three months from the beginning of the study

This is the primary outcome because of the link between cardiovascular mortality and hyperphosphatemia

Secondary Outcome Measures
NameTimeMethod
Changes in body composition assessed by bioelectrical impedance analysisBIA will be performed monthly for three months from the beginning of the study

Protein malnutrition causes a decrease in body cell mass. By bioelectrical impedance analysis (BIA) the changes in this parameter in the two experimental groups will be evaluated at one, two and three months from the beginning of the study.

Changes in serum albumin concentrationSerum albumin will be measured monthly for three months from the beginning of the study

Protein malnutrition causes a decrease in serum albumin concentration that will be, therefore, monitored, at one, two and three months from the beginning of the study.

Changes in hemoglobin levelshemoglobin level will be measured monthly for three months from the beginning of the study

Protein malnutrition causes a decrease in hemoglobin levels that will be, therefore, monitored, at one, two and three months from the beginning of the study.

Trial Locations

Locations (1)

Federico II University Hospital

🇮🇹

Napoli, Italy

© Copyright 2025. All Rights Reserved by MedPath